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strated that combining NS1 Ag to an early serologic test improved
Dengue diagnosis. If IgM has been extensively evaluated, there are
few data about IgA detection in association to NS1.
The purpose of these clinical studies was to evaluate the efﬁ-
ciency of combining dengueNS1Ag and anti-NS1 IgA antibodies for
the detection of Dengue infection during the acute phase in Asian
populations.
Methods & Materials: Evaluated kits were PlateliaTM Dengue
IgA Capture associated to PlateliaTM Dengue NS1 Ag for ELISA
part and RDT Dengue IgA/IgG associated to Dengue NS1 STRIP
for rapid testing. Sensitivity was performed on 216 samples from
patients with clinically conﬁrmed Dengue of 3 Asian countries:
Cambodia (n=135), India (n= 31) and Singapore (n=50). Speciﬁcity
was evaluated on 101 sera from 50 healthy Indian donors and 51
febrilepatients fromCambodia forwhichdengue infectionhasbeen
excluded.
Results: Depending on the population, the sensitivity ranged
from 48.5% to 93.3% for PlateliaTM Dengue IgA Capture assay versus
48.9% to 90.3% for IgM ELISA and 50% to 100% for the IgA rapid test.
When NS1 and IgA tests were combined, the sensitivity reached
93.5% to 98.0% for the ELISAs and 94.1% to 100% for the rapid
tests, compared to 94.9% for an “IgM+NS1” combination. The over-
all speciﬁcity of the NS1 and IgA combination in ELISA and rapid
test assays were 95,9% and 96,0% respectively. The analysis of NS1
and IgA ELISAs sensitivity related to the sampling time after fever
onset in Cambodia population showed that NS1 assay sensitivity
was lower and decreased earlier (day 5) in secondary infection than
in primary one (day 11).
Conclusion:Detectionof anti-NS1 IgAefﬁciently completesNS1
antigendetection in thediagnosisof acutedengue infection inAsian
populations. The combinationperforms aswell on ELISA as on rapid
test format and demonstrates similar performance to “IgM+NS1”.
Moreover, IgA appears to be especially useful in secondary infec-
tions and has also been described to be indicative of more severe
outcome in primary infections.
http://dx.doi.org/10.1016/j.ijid.2016.02.476
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Background: Infection controlmeasures to prevent nosocomial
transmission of novel pathogens like the Middle East Respiratory
Syndrome Coronavirus (MERS-CoV) require strict adherence to
guidelines. However, atypical presentations may mislead unwary
Emergency Department (ED) physicians, thus posing challenges.
Wepresent the investigationof aMERScasewith atypical presenta-
tion at theKing FahadMedical City (KFMC) inRiyadh in the summer
of 2015.
Methods&Materials: Thepatient’s charts and electronic health
records covering her two ED visits and subsequent intensive care
unit (ICU) admission were reviewed. Adhering to MOH protocols,
health careworkers (HCWs) exposed to thepatientweremonitored
for possible nosocomial MERS CoV transmission.
Results: The patient was a 77-year-old female with Diabetes
Mellitus, Hypertension, chronic kidney disease and chronic myelo-
cytic leukemia who presented twice at the ED, within 4 days. On
her ﬁrst visit, she was febrile (37.90C), had abdominal pain and
distension (ascites), nausea and vomiting. Four days earlier, she
had visited her primary hospital, known to be experiencing aMERS
outbreak at that time, for chemotherapy. Biochemical and micro-
biological testing of drained ascitic ﬂuid were unremarkable. She
was discharged the same day after spending 10 hours in the ED.
Three days later, she returned to the ED with progressive abdomi-
nal distension, worsening fever (38.80C) and deteriorating hepatic
and renal function. She developedpulseless electrical activity (PEA)
and asystole that required resuscitation for 19 minutes. She sur-
vived the arrest but clinically worsened and died 4 days in the
ICU. Despite 6 intra-hospital transfers (5 prior to MERS CoV con-
ﬁrmation) during her second visit, none of the exposed HCWs (n =
60) developed MERS; included are those who performed high risk
procedures (intubation and CPR) on her. However, epidemiological
investigation suggests she infected a post-mastectomy patient that
shared the waiting room with her while awaiting triage on her ﬁrst
ED visit. Both patients died.
Conclusion: This case of an atypical MERS case with multiple
exposures to several HCWs having varying levels of protection on
multiple occasions led to only one nosocomial case thus further
intensifying the mystery surrounding MERS CoV transmission.
http://dx.doi.org/10.1016/j.ijid.2016.02.477
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Background: Accredited Social Health Activists (ASHAs) are
located in rural Indianvillages topromotepositivehealth behaviors
and facilitate better health care utilization, including vaccination.
Wecalculated theaverage coverageof theBacillusCalmette-Guérin
vaccine (BCG); Diphtheria, Pertussis, and Tetanus vaccine (DPT);
polio vaccine; measles vaccine, and full vaccine coverage (BCG, 3
doses of DPT, 3 doses of polio, and measles vaccine) across districts
in India, and evaluated the impact of expanded ASHA presence on
changes in district-level vaccine coverage.
Methods & Materials: We used District Level Household and
Facility Survey data, collected in 2007-2008 (DLHS-3) and 2012-
2013 (DLHS-4); districts are the unit of analysis. The changes in
use of ASHAs and in vaccine coverage over time were calculated as
the difference between district-level values in DLHS-3 and DLHS-
